Castle Biosciences, Inc.CSTLNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+35.9%
5Y CAGR+40.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+35.9%/yr
vs +56.6%/yr prior
5Y CAGR
+40.6%/yr
Recent deceleration
Acceleration
-20.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.5x
Strong expansion
Streak
8 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$344.23M+3.7%
2024$332.07M+51.1%
2023$219.79M+60.4%
2022$137.04M+45.7%
2021$94.08M+50.2%
2020$62.65M+20.8%
2019$51.87M+127.6%
2018$22.79M+65.7%
2017$13.75M-